tyrphostin ag 1024 has been researched along with fulvestrant in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agboke, FA; Creswell, K; Fan, P; Jordan, VC; McDaniel, RE; Sweeney, EE; Zou, X | 1 |
1 other study(ies) available for tyrphostin ag 1024 and fulvestrant
| Article | Year |
|---|---|
Inhibition of c-Src blocks oestrogen-induced apoptosis and restores oestrogen-stimulated growth in long-term oestrogen-deprived breast cancer cells.
Topics: Animals; Apoptosis; Breast Neoplasms; Cadherins; Cell Proliferation; Estradiol; Estrogens; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; MCF-7 Cells; Mitogen-Activated Protein Kinases; Nuclear Proteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Snail Family Transcription Factors; src-Family Kinases; Transcription Factors; Twist-Related Protein 1; Tyrphostins | 2014 |